T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Kura Oncology
KURA
$793M
| $473K | ﹤0.01% |
58,094
+12,367
| +27% | +$106K |
|
2477
Inhibrx
INBX
$1.16B
| $472K | ﹤0.01% |
7,012
+1,678
| +31% | +$124K |
|
|
ONTF
2478
DELISTED
ON24
ONTF
| $472K | ﹤0.01% |
58,211
-10,459
| -15% | -$83.6K |
|
|
FFWM
2479
DELISTED
First Foundation Inc
FFWM
| $471K | ﹤0.01% |
79,763
+12,608
| +19% | +$76.5K |
|
|
HDSN
2480
Hudson Technologies
HDSN
$246M
| $471K | ﹤0.01% |
80,013
+6,307
| +9% | +$43.2K |
|
2481
AMC Entertainment Holdings
AMC
$2.45B
| $469K | ﹤0.01% |
478,528
+113,237
| +31% | +$146K |
|
|
RC
2482
Ready Capital
RC
$260M
| $468K | ﹤0.01% |
288,439
+5,569
| +2% | +$10.7K |
|
2483
Motorcar Parts of America
MPAA
$266M
| $467K | ﹤0.01% |
42,223
+2,349
| +6% | +$27K |
|
2484
Capital City Bank Group
CCBG
$897M
| $466K | ﹤0.01% |
10,717
+2,426
| +29% | +$104K |
|
2485
Daily Journal
DJCO
$826M
| $466K | ﹤0.01% |
966
+191
| +25% | +$104K |
|
2486
Prime Medicine
PRME
$547M
| $466K | ﹤0.01% |
133,755
+29,202
| +28% | +$111K |
|
2487
Solid Power
SLDP
$450M
| $465K | ﹤0.01% |
154,786
+35,056
| +29% | +$141K |
|
2488
iShares Core S&P Small-Cap ETF
IJR
$109B
| $463K | ﹤0.01% |
3,724
| – | – |
|
2489
Angi Inc
ANGI
$247M
| $462K | ﹤0.01% |
67,308
+14,236
| +27% | +$143K |
|
2490
Digital Turbine
APPS
$982M
| $462K | ﹤0.01% |
160,210
+19,939
| +14% | +$85.6K |
|
2491
Hyster-Yale Materials Handling
HY
$576M
| $462K | ﹤0.01% |
14,186
+1,319
| +10% | +$45.3K |
|
2492
Opko Health
OPK
$1.02B
| $462K | ﹤0.01% |
404,652
+37,461
| +10% | +$46.1K |
|
|
CTLP
2493
DELISTED
Cantaloupe
CTLP
| $461K | ﹤0.01% |
42,606
+8,429
| +25% | +$89.1K |
|
2494
Greif Class B
GEF.B
$4.13B
| $460K | ﹤0.01% |
5,244
+2,159
| +70% | +$182K |
|
2495
Mission Produce
AVO
$1.14B
| $458K | ﹤0.01% |
33,284
+7,782
| +31% | +$104K |
|
2496
Five Star Bancorp
FSBC
$1.01B
| $457K | ﹤0.01% |
12,094
+2,760
| +30% | +$106K |
|
2497
Levi Strauss
LEVI
$9.49B
| $456K | ﹤0.01% |
24,608
+2,000
| +9% | +$41K |
|
2498
TFS Financial
TFSL
$5.11B
| $455K | ﹤0.01% |
32,354
+5,198
| +19% | +$73.5K |
|
2499
MiMedx Group
MDXG
$630M
| $453K | ﹤0.01% |
114,524
+24,985
| +28% | +$126K |
|
2500
Voyager Therapeutics
VYGR
$181M
| $452K | ﹤0.01% |
117,078
-404,573
| -78% | -$1.59M |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.